ClinicalTrials.gg
Sign In
Not yet recruitingNCT07915284Updated Nov 4, 2026

Platelet Transfusion Thresholds in Non-Bleeding Patients

An observational study in Non Bleeding Patients With Thrombocytopenia, sponsored by Sohag University. Not yet recruiting at 1 site in Egypt. Open to participants aged 1 Month to 18 Years. Per ClinicalTrials.gov, last updated 2026-11-04.

Sponsored by Sohag University · Observational

Updated Nov 4, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
30
Ages
1 Month to 18 Years
Sex
All
01

Study summary

This is a study of platelet transfusion thresholds in patients with thrombocytopenia without bleeding and benifits of transfusion in those critically ill patients to prevent bleeding

Read the detailed description

This is a Prospective cohort hospital-based study To determine the threashold and outcome of platelet transfusion in non bleeding critically ill children in PICU

02

Conditions studied

  • Non Bleeding Patients With Thrombocytopenia

Keywords

  • Platelet transfusion threshold
  • Non-Bleeding patients
  • PICU
03

In context

Lead sponsor

Sohag University is the lead sponsor of 1,225 studies on the registry; 632 are open to participants now.

Browse Sohag University studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Month to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Pediatric patient admitted at PICU from age of day 1- to 18-year-old.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Duration of stay in PICU [more than 24 hours].

Exclusion criteria

Exclusion Criteria:

  • 1-Any patient with missing data or refusal to be in the study. 2-Patients with active bleeding. 3- Patients known to have chronic platelet disorder. 4- Patients on heparin, any anticoagulant or antiplatelet drugs.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
30 participants (estimated)
Target follow-up
10 Days
Patient registry
Yes

Groups and cohorts

  • Children from 1m to 18 year

    Platlet transfusion thresholds and clinical outcomes in Non Bleeding patients admitted to PICU

    Other: Platlet transfusion

Interventions

  • OtherPlatlet transfusion

    Platelt transfusion in Non Bleeding patients admitted to pediatric intensive care unit

06

What researchers measure

Primary outcomes

  1. Platelet transfusion .

    Time frame: 1 year

Secondary outcomes

  1. Bleeding.

    Time frame: 1 year

07

Study locations

1 site
08

References and documents

Publications

  • https://med.sohag-univ.edu.eg/main/

Individual participant data

Plan to share: No — individuals participant data will not be shared due to privacy protection policies at Sohag university Hospital

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2026; primary completion for Sep 2027, 10 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 18, 2026
First posted
Nov 4, 2026
StartEst.
Oct 30, 2026
Primary completionEst.
Sep 10, 2027
CompletionEst.
Sep 15, 2027
Last update
Nov 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 4, 2026
Show all 1 update
  1. Nov 4, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07915284
Lead sponsor
Sohag University
Responsible party
Rehab Mohamed Abdellatif (Pediatric residat-sohag university hospitals, Sohag University) — Principal investigator
First posted
Nov 4, 2026
Start date
Oct 30, 2026 (estimated)
Primary completion
Sep 10, 2027 (estimated)
Completion
Sep 15, 2027 (estimated)
Last update
Nov 4, 2026

Study contacts

Rehab mohammed abdellatif ali
Contact
rebom66@gmail.com
+201127021954

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Sohag University →

Start the discussion